Accelerating Strep A vaccine development | SAVAC Stakeholders Meeting
Speakers during the virtual SAVAC Stakeholders Meeting on March 11, 2021
Decreasing the burden of Strep A disease in the most in need
The mission of the Strep A Vaccine Global Consortium (SAVAC) is to ensure that safe, effective and affordable Strep A vaccines are available and implemented to decrease the burden of Strep A disease in the most in need.
The first SAVAC stakeholders meeting organized by the SAVAC Executive Committee (chaired by Dr. Jerome Kim, Director General of IVI, and co-chaired by Prof. Andrew Steer, Murdoch Children’s Research Institute) and the IVI Secretariat was held on March 11, 2021. The virtual meeting gathered more than a hundred participants from all over the world.
The objectives of the meeting were to review the SAVAC achievements and work in progress, discuss critical issues of Strep A vaccine development—which includes burden of disease, vaccine safety, correlates of protection, vaccine landscape, business case and investment case as components of a full value of vaccine assessment—seek advice and recommendations on next steps and increase awareness and interest of funders.
We are very grateful to the outstanding speakers and participants who contributed to the great success of the meeting, and particularly grateful to the Wellcome Trust’s generosity in funding SAVAC.
Watch a full recording of the meeting here:
Young researchers of the KNUST-IVI Collaborating Center together with Dr. Jerome Kim, DG of IVI